COVID Vaccines are the new lifeline of a modern healthcare system. In the last 6 weeks, we have witnessed a massive accumulation of resources to drive COVID vaccine supply around the world. In these testing times, where even the most formidable economies are failing to meet demands, this update from Angola will cheer up everyone. Angola, where 88% of the rural population lives in chronic poverty, has managed to record 1 million milestone in COVID vaccines administered.
According to WHO, Angola has recorded 36,600 confirmed cases and 800+ deaths.
Role of AstraZeneca-Oxford As Part of COVAX COVID Vaccines Program
As on 14 June 2021, Angola has reached the milestone of more than one million doses of COVID-19 vaccines administered after receiving the first doses from COVAX, a partnership between Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, which aims to ensure equitable distribution of vaccines against COVID-19, worldwide.
The Angolan Ministry of Health announced the milestone of more than one million doses of vaccines administered to the population, after receiving 624 000 doses of the AstraZeneca-Oxford vaccine on 2 March this year from the Serum Institute of India, as part of the COVAX initiative, and subsequently, in April 2021, an additional 495 000 doses.
Angola Received A Total of 2.17 Million Doses of the COVID-19 Vaccine
A total of 2.17 million doses of the COVID-19 vaccine were allocated to Angola until June 2021, as part of the doses donated to more than 92 low-income countries by partners of the COVAX initiative.
According to the WHO Representative in Angola, Dr Djamila Cabral, the positive results recorded in the country reflect the commitment of the authorities and the joint efforts of society to fight the COVID-19 pandemic.
Medtech Insights: Tackling Surges In Severe COVID-19 Cases In Africa
“We congratulate Angola for the country’s strong engagement and determination which began with a timely preparation of a vaccination plan and quick regulatory oversight, resulting in a positive response from COVAX and the timely procurement of vaccines for the protection of the Angolan people,” she said. “WHO is pleased to be part of Angola’s efforts to protect the health of all and save lives.”
To ensure safe and equitable access to the COVID-19 vaccines and the success of the vaccination campaign, the Angolan health authorities have developed, with the support of their partners—WHO, United Nations Children’s Fund (UNICEF) and Gavi—a National Vaccination and Vaccine Distribution Plan. The plan includes the prioritization of target groups, strengthening of infrastructure for vaccination and the cold chain, the training of vaccinators, the continuous management of misinformation, the creation of an electronic vaccination registration system and the creation of high-performance vaccination centers.
Role of UNICEF and WHO In Angola’s COVID Vaccine Drive
UNICEF’s Representative in Angola, Ivan Yerovi, affirmed that this is a remarkable milestone and testimony of the hard work of health workers, government officials and others involved in the campaign.
“We cannot stop until the most vulnerable family of Angola is safe. We are all together in supporting the global vaccination campaign. UNICEF will not leave any stone unturned to support the Government of Angola in their efforts,” he said.
AlefEdge Introduces Advisory Board Of Industry Leaders To Scale Commercialization Of The 5G Edge API
In Angola, around 30 000 doses of vaccine are currently being administered daily, with the expectation of reaching the target of at least 20% of the population by the end of the year.
However, the challenge of scarcity and inequality of access to COVID-19 vaccines may slow down the country’s vaccination drive. WHO, UNICEF and other COVAX partners renew their appeal to the international community to accelerate dose sharing of excess vaccines and the promotion of their production worldwide.
[To share your insights, please write to us at sghosh@martechseries.com]
Comments are closed.